Priya Singhal - Feb 9, 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal
Stock symbol
BIIB
Transactions as of
Feb 9, 2024
Transactions value $
-$190,456
Form type
4
Date filed
2/13/2024, 06:06 PM
Previous filing
Feb 9, 2024
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1.21K +29.58% $0.00 5.31K Feb 9, 2024 Direct
transaction BIIB Common Stock Tax liability -$90.1K -374 -7.04% $240.98 4.94K Feb 9, 2024 Direct
transaction BIIB Common Stock Sale -$100K -419 -8.49% $239.45 4.52K Feb 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1.21K -50% $0.00 1.21K Feb 9, 2024 Common Stock 1.21K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on February 10, 2022 and will vest in three equal installments on each anniversary of the grant date.